EUVIMEDEUVIMED entdecken
Crossref

Inhibition of the MyD88 / NF ‐ κB pathway alters the Th1/Th2 balance to exacerbate liver injury and hepatic fibrosis in alveolar echinococcosis

Liang Wang, Jiang Zhu, Mengen Meng, Shiyu Zhu, Yuyu Ma, Tanfang Zhou, Xiumin Ma iD, Kalibixiati Aimulajiang iD

The FASEB Journal · 2025

DOI: 10.1096/fj.202402423rr ↗

Kurz gefasst

Fachartikel in der Zeitschrift The FASEB Journal, 2025. Verfasst von Liang Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Pathogenesis, Prevention and Treatment of High Incidence Diseases in Central Asia, Clinical Laboratory Center, Tumor Hospital…. Hauptthemen laut MEDLINE: Myeloid Differentiation Factor 88, Signal Transduction, Liver Cirrhosis, NF-kappa B. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: work station of autonomy region third peoples hospital, the Key Project of Natural Science Foundation of Xinjiang Autonomous Region, the National Natural Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alveolar echinococcosis (AE) is a severe human‐veterinary parasitic disease. However, the Myeloid differentiation factor 88 (MyD88) signaling pathway has seldom been explored in the context of AE. Protoscoleces (PSC) of alveolar echinococcosis were obtained from the liver tissues of gerbils for breeding purposes, and then used to establish a mouse model of alveolar echinococcosis. This mouse model was utilized to block the MyD88 signaling pathway, with the aim of analyzing the associated fibrotic and inflammatory responses. To evaluate the expression of fibrotic molecules, Masson staining and Quantitative reverse transcription polymerase chain reaction (qRT‐PCR) were performed. Moreover, qRT‐PCR and Western blotting (WB) were adopted to investigate the alterations in the protein expression levels of MyD88 and Nuclear factor‐κB p65 (NF‐κB p65). In parallel, the human monocyte cell line RAW 264.7was cultured in vitro. After stimulation of RAW 264.7 with Echinococcus multilocularis protein (Emp), the MyD88 signaling pathway was blocked using TJ‐M2010‐5. Subsequently, the protein and mRNA expression levels of MyD88 and NF‐κB p65 were determined by WB and qRT‐PCR, respectively, while the dynamic changes in the proportion of macrophages were monitored by flow cytometry. The results demonstrated that the compound TJ‐M2010‐5 could effectively suppress the MyD88 signaling pathway, leading to a significant down‐regulation of the expression levels of both MyD88 and Nuclear factor‐κB p65 (NF‐κB p65). Moreover, the blockade of the MyD88 signaling pathway perturbed the balance of the Th1/Th2 immune response. Consequently, this imbalance further aggravated liver fibrosis and liver injury. The blockade of the MyD88 signaling pathway led to a disruption of the balance among T‐lymphocyte subpopulations, an enhancement of Th2 type immune responses, and a reduction in pro‐inflammatory responses. These alterations ultimately culminated in aggravated liver injury and fibrosis in the context of alveolar echinococcosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myeloid Differentiation Factor 88Signal TransductionLiver CirrhosisNF-kappa BTh1 CellsEchinococcosis, HepaticTh2 CellsTh1-Th2 BalanceEchinococcosisAnimalsMiceHumansRAW 264.7 CellsEchinococcus multilocularisLiverMaleMice, Inbred C57BLGerbillinaeTranscription Factor RelA

Stichwörter der Autor:innen

MyD88/NF‐κB signaling pathwayTJ‐M2010‐5 (MyD88 inhibitor)Th1/Th2alveolar echinococcosisfibrosis

Substanzen

Myeloid Differentiation Factor 88NF-kappa BMyd88 protein, mouseTranscription Factor RelA

Autor:innen und Institutionen

  • State Key Laboratory of Pathogenesis, Prevention and Treatment of High Incidence Diseases in Central Asia, Clinical Laboratory Center, Tumor Hospital Affiliated to Xinjiang Medical University, Urumqi, Xinjiang, P.R. Chi…
  • The Fifth Clinical Medical College of Xinjiang Medical University, Urumqi, Xinjiang, China.
  • Department of Abdominal Surgery, The Third People Hospital of Xinjiang Uygur Autonomous Region, Urumqi 830000, China., Urumqi, Xinjiang, China.
  • State Key Laboratory of Pathogenesis, Prevention and Treatment of High Incidence Diseases in Central Asia, Clinical Medicine Institute, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang, Chi…

ORCID-Profile: Xiumin Ma, Kalibixiati Aimulajiang

Förderung

  • work station of autonomy region third peoples hospital
  • the Key Project of Natural Science Foundation of Xinjiang Autonomous Region
  • the National Natural Science Foundation
  • the Causes and prevention of high incidence in Central Asia jointly built by provinces and ministries Open project of state key laboratory
  • the State Key Laboratory of Pathogenesis, Prevention and Treatment of High Incidence Diseases in Central Asia, Xinjiang Uygur Autonomous Region Graduate Innova…
  • the Key R&D Programme Projects of Xinjiang Uygur Autonomous Region, China
  • the Natural Science Foundation of Xinjiang Uygur Autonomous Region, China

Zitieren

APA

Wang, L., Zhu, J., Meng, M., Zhu, S., Ma, Y., Zhou, T., Ma, X., & Aimulajiang, K. (2025). Inhibition of the MyD88 / NF ‐ κB pathway alters the Th1/Th2 balance to exacerbate liver injury and hepatic fibrosis in alveolar echinococcosis. The FASEB Journal. https://doi.org/10.1096/fj.202402423rr

Vancouver

Wang L, Zhu J, Meng M, Zhu S, Ma Y, Zhou T, et al. Inhibition of the MyD88 / NF ‐ κB pathway alters the Th1/Th2 balance to exacerbate liver injury and hepatic fibrosis in alveolar echinococcosis. The FASEB Journal. 2025. doi:10.1096/fj.202402423rr

BibTeX
@article{Wang2025,
  author = {Wang, Liang and Zhu, Jiang and Meng, Mengen and Zhu, Shiyu and Ma, Yuyu and Zhou, Tanfang and Ma, Xiumin and Aimulajiang, Kalibixiati},
  title = {Inhibition of the MyD88 / NF ‐ κB pathway alters the Th1/Th2 balance to exacerbate liver injury and hepatic fibrosis in alveolar echinococcosis},
  journal = {The FASEB Journal},
  year = {2025},
  doi = {10.1096/fj.202402423rr}
}
Kostenlos starten →